SHC stock icon

Sotera Health

15.77 USD
-0.14
0.88%
At close Oct 17, 4:00 PM EDT
After hours
15.77
+0.00
0.00%
1 day
-0.88%
5 days
3.82%
1 month
-5.34%
3 months
18.13%
6 months
46.70%
Year to date
-5.85%
1 year
10.90%
5 years
-37.17%
 

About: Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three segments: Sterigenics, Nordion, and Nelson Labs. Sterigenics provides outsourced terminal sterilization and irradiation services for medical device, pharmaceutical, food safety, and advanced applications; Nordion provides Co-60 and gamma irradiators, which are the key components to the gamma sterilization process; and Nelson Labs provides outsourced microbiological and analytical chemistry testing for the medical device and pharmaceutical industries. Its geographical segments are the United States, Canada, Europe, and other regions.

Employees: 3,000

0
Funds holding %
of 6,740 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

32% more first-time investments, than exits

New positions opened: 41 | Existing positions closed: 31

19% more repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 62

5% more funds holding

Funds holding: 195 [Q1] → 205 (+10) [Q2]

0.33% more ownership

Funds ownership: 92.56% [Q1] → 92.89% (+0.33%) [Q2]

1% less capital invested

Capital invested by funds: $3.14B [Q1] → $3.12B (-$26.9M) [Q2]

11% less funds holding in top 10

Funds holding in top 10: 9 [Q1] → 8 (-1) [Q2]

28% less call options, than puts

Call options by funds: $296K | Put options by funds: $413K

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$17
8%
upside
Avg. target
$17
8%
upside
High target
$17
8%
upside

2 analyst ratings

positive
100%
neutral
0%
negative
0%
Barclays
Luke Sergott
50% 1-year accuracy
24 / 48 met price target
8%upside
$17
Overweight
Maintained
6 Aug 2024
RBC Capital
Sean Dodge
66% 1-year accuracy
31 / 47 met price target
8%upside
$17
Outperform
Reiterated
6 Aug 2024

Financial journalist opinion

Charts implemented using Lightweight Charts™